
RAAPID, an AI-powered risk adjustment company, serves Medicare Advantage plans, ACOs, and health systems, linking every diagnosis to encounter-based evidence.
raapidinc.comCrawled Oct 24, 2026
AI ML DL technologies have the ability to accurately identify and predict patient health risks, allowing for earlier interventions and better outcomes.
RAAPID’s AI-driven risk adjustment technology and HCC coding review services optimize health plan revenue and RAF scores.
The company provides a brochure on its HCC Coding Technology Solutions & Services.
OCR technology extracts medical information from documents like charts and reports.
The CMS-HCC Model V28 is active, with changes from V24 including a 3.12% drop in RAF scores, and guidance on maintaining defensible coding under audit.
The company offers insights and solutions for managing value-based care risk adjustment coding for MA organizations, coders, and providers.
Prospective risk adjustment shifts HCC coding to the point of care, allowing clinicians to confirm conditions with evidence.
RAAPID’s AI-powered HCC coding solution improves Medicare Advantage risk adjustments by reducing coding gaps and increasing reimbursement accuracy.
RAAPID was featured in the May 2026 KLAS Emerging Company Spotlight, highlighting customer ratings and real-world insights.
RAAPID’s press room includes digital footprints on leading online press release distribution platforms and healthcare properties.
LOUISVILLE, Ky., April 22, 2025 /PRNewswire/ -- RAAPID, delivering purpose-built AI-powered risk adjustment platform for risk-bearing payers and providers
RAAPID is a healthcare technology company specializing in AI-enabled risk adjustment solutions for payers, providers, and support organizations, funded by Microsoft and certified by Great Place to Work.
An infographic compares traditional and RAAPID clinical chart review methods with a comparative analysis.
Healthcare technology advisor Daniel Chaitow brings M&A expertise from Innovaccer and PWC to guide RAAPID's AI-powered risk adjustment growth strategy.
Don Antonucci, CEO of Providence Health Plan and former Blue Shield of California SVP, guides RAAPID's AI risk adjustment solutions with 25+ years payer expertise.
RAAPID’s advisory board includes healthcare executives from Microsoft, AdventHealth, Providence Health Plan, and Blue Shield, advising on AI risk adjustment solutions.
Terry Shaw, former AdventHealth CEO and Modern Healthcare's Top 100 Influencer, brings health system leadership expertise to RAAPID's risk adjustment solutions.
The company develops AI-driven solutions for healthcare payers, providers, and medical coders in the risk adjustment space.
RAAPID offers demos of its AI-powered risk adjustment solutions, covering RADV audit defense, HCC coding, and revenue protection.
RAAPID's neuro-symbolic AI risk adjustment platform delivers 98% accuracy, 10:1 ROI, and audit-ready HCC coding for health plans and providers.
RAAPID’s privacy policy details data collection, use, and protection, with HIPAA and HITRUST certification to safeguard patient health information.
RAAPID’s terms of service outline the use of its AI-powered risk adjustment platform, APIs, and healthcare solutions.
RAAPID secures investment from Healthworx, the investment arm of CareFirst, Inc., to advance its 'Audit-First' AI for defensible risk adjustment in Medicare Advantage. The partnership follows collaborations with Microsoft and UPMC Enterprises, positioning RAAPID as a key player in standardizing risk-adjustment practices amid heightened CMS scrutiny. Healthworx’s involvement underscores growing industry adoption of AI-driven compliance solutions.
Apr 2026VentureBeatNews article
UPMC Enterprises and Microsoft’s venture fund M12 are backing **RAAPID**, an AI startup specializing in risk adjustment and medical coding. The Series A funding round highlights growing investment in AI-driven healthcare automation tools. RAAPID aims to streamline complex billing and coding processes for providers.
Mar 2026Becker's Hospital Review | Healthcare News & AnalysisNews article
RAAPID raises additional Series A funding to expand its neuro-symbolic AI platform for medical coding. The company’s Clinical AI Platform automates Medicare Advantage risk adjustment and coding tasks. Investors include UPMC Enterprises and Microsoft’s venture arm, M12.
Mar 2026VentureBeatNews article
RAAPID secures Series A funding from M12 and Microsoft Venture Fund to scale its AI-powered risk adjustment platform. The Louisville-based company develops solutions for processing unstructured medical data in healthcare. Investors back the technology to improve accuracy in risk assessment for providers.
Jan 2025Yahoo FinanceNews article